Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells

被引:67
作者
Blumenthal, RL
Campbell, DE
Hwang, P
DeKruyff, RH
Frankel, LR
Umetsu, DT
机构
[1] Stanford Univ, Dept Pediat, Div Immunol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pediat, Div Immunol, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Pediat, Div Allergy & Crit Care Med, Stanford, CA 94305 USA
关键词
alveolar macrophages; tolerance; T cells; immune privilege; CD86; CD28;
D O I
10.1067/mai.2001.112845
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Alveolar macrophages (AMCs) are the most abundant phagocytic cells in the lung, but they present antigen poorly to T cells, Objectives: The objectives of our studies were to more clearly define the mechanisms by which AMCs present antigen to T cells and to determine whether AMCs actively inhibit T-cell activation, Methods: We studied purified human CD4 T cells and compared the capacity of allogeneic AMCs and peripheral blood monocytes to induce T-cell proliferation and cytokine production. Results: We previously demonstrated that human AMCs fail to upregulate expression of B7-1 and B7-2 on stimulation with IFN-gamma, We now demonstrate that AMCs actively induce T-cell unresponsiveness (functional inactivation) in an antigen-specific manner and reduce the capacity of CD4 T cells to respond on secondary stimulation. The induction of unresponsiveness was reversed by the addition of CD28 costimulation or IL-2, However, interruption of Fas/Fas ligand interactions or of B7/CTLA-4 interactions did not prevent unresponsiveness, indicating that neither CTLA-4 triggering nor Fas-induced apoptosis was involved in the induction of T-cell unresponsiveness. Conclusions: These studies indicate that AMCs actively tolerize CD4 T cells in an antigen-specific fashion. We propose that AMCs mediate a form of immune privilege in the lungs that effectively limits immune responses in the pulmonary compartment but has little effect on systemic immunity.
引用
收藏
页码:258 / 264
页数:7
相关论文
共 45 条
[1]  
Agea E, 1998, CLIN EXP ALLERGY, V28, P1359
[2]  
Banchereau J, 1997, TRANSFUS SCI, V18, P313
[3]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[4]   REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION [J].
BEVERLY, B ;
KANG, SM ;
LENARDO, MJ ;
SCHWARTZ, RH .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) :661-671
[5]  
BILYK N, 1995, IMMUNOLOGY, V86, P231
[6]  
Bingisser RM, 1998, J IMMUNOL, V160, P5729
[7]  
Blotta MH, 1996, J IMMUNOL, V156, P3133
[8]   Immune functions and immunopathology of the mucosa of the upper respiratory pathways [J].
Brandtzaeg, P ;
Jahnsen, FL ;
Farstad, IN .
ACTA OTO-LARYNGOLOGICA, 1996, 116 (02) :149-159
[9]   Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes [J].
Burastero, SE ;
Magnani, Z ;
Confetti, C ;
Abbruzzese, L ;
Oddera, S ;
Balbo, P ;
Rossi, GA ;
Crimi, E .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (06) :1136-1142
[10]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752